284 related articles for article (PubMed ID: 8773434)
1. Procoagulant activity on injured arteries and associated thrombi is mediated primarily by the complex of tissue factor and factor VIIa.
Speidel CM; Thornton JD; Meng YY; Eisenberg PR; Edgington TS; Abendschein DR
Coron Artery Dis; 1996 Jan; 7(1):57-62. PubMed ID: 8773434
[TBL] [Abstract][Full Text] [Related]
2. Tissue factor mediates prolonged procoagulant activity on the luminal surface of balloon-injured aortas in rabbits.
Speidel CM; Eisenberg PR; Ruf W; Edgington TS; Abendschein DR
Circulation; 1995 Dec; 92(11):3323-30. PubMed ID: 7586321
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of factor Xa is more efficient than factor VIIa-tissue factor complex blockade at facilitating coronary thrombolysis in the canine model.
Lefkovits J; Malycky JL; Rao JS; Hart CE; Plow EF; Topol EJ; Nicolini FA
J Am Coll Cardiol; 1996 Dec; 28(7):1858-65. PubMed ID: 8962577
[TBL] [Abstract][Full Text] [Related]
4. Role of thrombin compared with factor Xa in the procoagulant activity of whole blood clots.
Prager NA; Abendschein DR; McKenzie CR; Eisenberg PR
Circulation; 1995 Aug; 92(4):962-7. PubMed ID: 7641380
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological interruption of acute thrombus formation with minimal hemorrhagic complications by a small molecule tissue factor/factor VIIa inhibitor: comparison to factor Xa and thrombin inhibition in a nonhuman primate thrombosis model.
Suleymanov OD; Szalony JA; Salyers AK; LaChance RM; Parlow JJ; South MS; Wood RS; Nicholson NS
J Pharmacol Exp Ther; 2003 Sep; 306(3):1115-21. PubMed ID: 12829728
[TBL] [Abstract][Full Text] [Related]
6. The role of thrombin in coronary artery thrombosis.
Eisenberg PR
Coron Artery Dis; 1996 Jun; 7(6):400-8. PubMed ID: 8889355
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of antithrombotic effect and bleeding time prolongation in rabbits by inhibiting tissue factor function.
Himber J; Kirchhofer D; Riederer M; Tschopp TB; Steiner B; Roux SP
Thromb Haemost; 1997 Sep; 78(3):1142-9. PubMed ID: 9308768
[TBL] [Abstract][Full Text] [Related]
8. Effect of selective factor Xa inhibition on arterial thrombus formation triggered by tissue factor/factor VIIa or collagen in an ex vivo model of shear-dependent human thrombogenesis.
Orvim U; Barstad RM; Vlasuk GP; Sakariassen KS
Arterioscler Thromb Vasc Biol; 1995 Dec; 15(12):2188-94. PubMed ID: 7489241
[TBL] [Abstract][Full Text] [Related]
9. Importance of factor Xa in determining the procoagulant activity of whole-blood clots.
Eisenberg PR; Siegel JE; Abendschein DR; Miletich JP
J Clin Invest; 1993 May; 91(5):1877-83. PubMed ID: 8486759
[TBL] [Abstract][Full Text] [Related]
10. The factor VIII bypassing activity of prothrombin complex concentrates: the roles of factor VIIa and of endothelial cell tissue factor.
Teitel JM
Thromb Haemost; 1991 Nov; 66(5):559-64. PubMed ID: 1803620
[TBL] [Abstract][Full Text] [Related]
11. Prolonged activation of prothrombin on the vascular wall after arterial injury.
Ghigliotti G; Waissbluth AR; Speidel C; Abendschein DR; Eisenberg PR
Arterioscler Thromb Vasc Biol; 1998 Feb; 18(2):250-7. PubMed ID: 9484990
[TBL] [Abstract][Full Text] [Related]
12. Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulation.
Kjalke M; Monroe DM; Hoffman M; Oliver JA; Ezban M; Roberts HR
Thromb Haemost; 1998 Oct; 80(4):578-84. PubMed ID: 9798973
[TBL] [Abstract][Full Text] [Related]
13. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro.
Torbet J
Thromb Haemost; 1995 May; 73(5):785-92. PubMed ID: 7482404
[TBL] [Abstract][Full Text] [Related]
14. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
Kruithof EK; Mestries JC; Gascon MP; Ythier A
Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans.
Jilma B; Marsik C; Mayr F; Graninger MT; Taylor FB; Ribel MC; Erhardtsen E; Handler S; Eichler HG
Clin Pharmacol Ther; 2002 Oct; 72(4):403-10. PubMed ID: 12386642
[TBL] [Abstract][Full Text] [Related]
16. Intimal tissue factor activity is released from the arterial wall after injury.
Giesen PL; Fyfe BS; Fallon JT; Roque M; Mendlowitz M; Rossikhina M; Guha A; Badimon JJ; Nemerson Y; Taubman MB
Thromb Haemost; 2000 Apr; 83(4):622-8. PubMed ID: 10780328
[TBL] [Abstract][Full Text] [Related]
17. Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis.
Kaiser B; Fareed J
Thromb Haemost; 1996 Oct; 76(4):615-20. PubMed ID: 8903005
[TBL] [Abstract][Full Text] [Related]
18. Sustained inhibition of whole-blood clot procoagulant activity by inhibition of thrombus-associated factor Xa.
McKenzie CR; Abendschein DR; Eisenberg PR
Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1285-91. PubMed ID: 8857926
[TBL] [Abstract][Full Text] [Related]
19. Fibrin-rich and platelet-rich thrombus formation on neointima: recombinant tissue factor pathway inhibitor prevents fibrin formation and neointimal development following repeated balloon injury of rabbit aorta.
Asada Y; Hara S; Tsuneyoshi A; Hatakeyama K; Kisanuki A; Marutsuka K; Sato Y; Kamikubo Y; Sumiyoshi A
Thromb Haemost; 1998 Sep; 80(3):506-11. PubMed ID: 9759635
[TBL] [Abstract][Full Text] [Related]
20. Expression and assembly of procoagulant complexes by human pleural mesothelial cells.
Kumar A; Koenig KB; Johnson AR; Idell S
Thromb Haemost; 1994 May; 71(5):587-92. PubMed ID: 8091385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
